SlideShare une entreprise Scribd logo
1  sur  19
A short
Introduction to
Drug design and
discovery
neethuasokan
What is a drug?
• Defined composition with a pharmacological effect
• Regulated by the Food and Drug Administration (FDA)
• What is the process of Drug Discovery and Development?
neethuasokan
Drug designing
1)challenging
2)Expensive
3)Time consuming
So, Multidisciplinary approach:
Computational tools, methodologies for structure guided
approach + Global gene expression data analysis by
softwares.
Hence,
1)Efficiency increased
2)Cost effectiveness
3)Time saved
4)Strategies to overcome toxic side effects
neethuasokan
Drug design
Hence,
1)Efficiency increased
2)Cost effectiveness
3)Time saved
4)Strategies to overcome toxic side effects
neethuasokan
DRUG DESIGN
2 ways:
A)Development of ligands with desired properties
for targets having known structure and functions.
B)Development of ligands with predefined
properties for targets whose structural
information may be or may not be known.
This, unknown target information can be found by
global gene expression data.
neethuasokan
w drugs are taken?
 Inhaled
 Injection
 Orally
 Snorted
 Transdermal (Patches)
 Through body orifices
neethuasokan
A Little History of Computer
Aided Drug Design
• 1960’s - Viz - review the target - drug interaction
• 1980’s- Automation - high trhoughput target/drug selection
• 1980’s- Databases (information technology) - combinatorial
libraries
• 1980’s- Fast computers - docking
• 1990’s- Fast computers - genome assembly - genomic based
target selection
• 2000’s- Vast information handling - pharmacogenomics
neethuasokan
Drug Designing Methods:
• Databases:
PDB: Experimentally determined structures.
NCI: National Cancer Institute.
Pubchem: Bulk data available for QSAR for lead discovery.
3D MIND: Information about cytotoxic potency for 60 human cancer
cell lines.
OSIRIS: To draw chemical structures and predict drug like properties
like absorption in body etc.
Links at the bottom of the paper.
Autodock and Dock6 for docking
neethuasokan
Toxicity
• Toxicology is the study of toxic effects of drugs or
other substances on the body
• Physicians must weigh therapeutic benefit against the
risk of toxicity
• Some drugs have a narrow therapeutic-toxic index
called the “therapeutic window”
• very little difference exists in the therapeutic versus toxic
blood level
• laboratory drug levels are ordered if the physician suspects
toxicity
• Toxicity of a drug may affect route of administration
neethuasokan
Discovery and Development
• The time from conception to approval of a new drug is
typically 10-15 years
• The vast majority of molecules fail along the way
• The estimated cost to bring to market a successful drug is now
$800 million!! (Dimasi, 2000)
neethuasokan
Drugs and the Discovery
Process• Small Molecules
• Natural products
• fermentation broths
• plant extracts
• animal fluids (e.g., snake venoms)
• Synthetic Medicinal Chemicals
• Project medicinal chemistry derived
• Combinatorial chemistry derived
• Biologicals
• Natural products (isolation)
• Recombinant products
• Chimeric or novel recombinant products
neethuasokan
BASICCONCEPT OFTHE
DRUGMANAGEMENTCYCLE
neethu asokan
Management Support
Procurement
Planning
Distribution
Utilization
Storage
Advantages
 Patients receive optimal pharmaceutical therapy
 Enables consistent and predictable treatment from all
levels of providers and at all locations
 Allows for improved availability of medicines because
of consistent and known usage patterns
 Helps provide good outcomes because patients are
receiving the best treatment regimen available
 Lowers cost
neethuasokan
Disadvantages
 Inaccurate guidelines will provide the wrong information. Often
guidelines are based on existing practices rather than
evidenced-based medicine.
 Guideline development and maintenance takes much time and
effort.
 STGs may give false sense of security and discourage ongoing
critical thinking
neethuasokan
The biological targets of drug action
neethuasokan
• Medicine – a legal substance used to treat an illness or
ailment
• Side effects – an effect that accompanies the expected
effect of a drug
• Drug allergies – an unwanted effect that accompanies
the desired effect of a drug
• Overdose – a serious sometimes fatal reaction to a
large dose of a drug
• Dose – an exact amount of a drug
neethuasokan
Issues in Drug Discovery
• Hits and Leads - Is it a “Druggable” target?
• Resistance
• Pharmacodynamics
• Delivery - oral and otherwise
• Metabolism
• Solubility, toxicity
• Patentability
neethuasokan
Drug Discovery Without a Lead
Penicillins
1928 - Fleming
• mold spore contaminates culture dish
• left dish on bench top while on vacation
• weather was unseasonably cold
• particular strain of mold was a good penicillin producer
Bacteria lysed by green mold; could not reproduce effect -
serendipity.
Could not get penicillin in a useful clinical form
1940 - Florey (Oxford)
Succeeded in producing penicillin in a useful clinical form.
neethuasokan
Conclusion
• Cancer is common in all the ages and it shows metastasis,
angiogenesis and cell death, etc.
• So, drugs to cure cancer are necessary.
• Except toxicity, drugs are quite tolerable so they are combined
with other drugs.
• Comparative analysis of gene expression levels between drug
treated and non-treated condition should be studied.
• If getting superior quality drug than the available ones, clinical
trial phases can be performed on them.
neethuasokan

Contenu connexe

Tendances

Molecular docking
Molecular dockingMolecular docking
Molecular docking
palliyath91
 

Tendances (20)

drug discovery- history, evolution and stages
drug discovery- history, evolution and stagesdrug discovery- history, evolution and stages
drug discovery- history, evolution and stages
 
Structure base drug design
Structure base drug designStructure base drug design
Structure base drug design
 
Pharmacophore mapping
Pharmacophore mapping Pharmacophore mapping
Pharmacophore mapping
 
Pharmacophore modeling
Pharmacophore modelingPharmacophore modeling
Pharmacophore modeling
 
Molecular docking
Molecular dockingMolecular docking
Molecular docking
 
Rational drug design
Rational drug designRational drug design
Rational drug design
 
docking
docking docking
docking
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designing
 
SAR & QSAR
SAR & QSARSAR & QSAR
SAR & QSAR
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
QSAR
QSARQSAR
QSAR
 
Docking
DockingDocking
Docking
 
Combinatorial chemistry
Combinatorial chemistry Combinatorial chemistry
Combinatorial chemistry
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and development
 
MOLECULAR DOCKING
MOLECULAR DOCKINGMOLECULAR DOCKING
MOLECULAR DOCKING
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
 
Pharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningPharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug Designing
 
Docking techniques
Docking techniquesDocking techniques
Docking techniques
 
Drug discovery hit to lead
Drug discovery hit to leadDrug discovery hit to lead
Drug discovery hit to lead
 
Pharmacophore modeling and docking techniques
Pharmacophore modeling and docking techniquesPharmacophore modeling and docking techniques
Pharmacophore modeling and docking techniques
 

Similaire à Drug design and discovery ppt

Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
pharmacywall
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
pharmacywall
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
pharmacywall
 
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.comDrug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Neelima Sharma
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
swati2084
 
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGNDRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
AADYARAJPANDEY1
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
Shaikh Abusufyan
 

Similaire à Drug design and discovery ppt (20)

An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry
 
Drud Discovery - Dr. Amsavel.pdf
Drud Discovery -  Dr. Amsavel.pdfDrud Discovery -  Dr. Amsavel.pdf
Drud Discovery - Dr. Amsavel.pdf
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.comDrug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
 
Principles of pharmcology and pharmacotherapeutics
Principles of pharmcology and pharmacotherapeuticsPrinciples of pharmcology and pharmacotherapeutics
Principles of pharmcology and pharmacotherapeutics
 
Pharmacology.
Pharmacology.Pharmacology.
Pharmacology.
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
drugs and development
drugs and development drugs and development
drugs and development
 
Scope of pharmacology
Scope of pharmacologyScope of pharmacology
Scope of pharmacology
 
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGNDRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
 
Pharmacovigilance: An umbrella word for DRug safety.
Pharmacovigilance: An umbrella word for DRug safety.Pharmacovigilance: An umbrella word for DRug safety.
Pharmacovigilance: An umbrella word for DRug safety.
 
Reverse Pharmacology
Reverse PharmacologyReverse Pharmacology
Reverse Pharmacology
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Drug discoveries by serendipity
Drug discoveries by serendipityDrug discoveries by serendipity
Drug discoveries by serendipity
 
Reverse pharmacology scope in India
Reverse pharmacology scope in IndiaReverse pharmacology scope in India
Reverse pharmacology scope in India
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
 
1_INTRODUCTION TO PHARMACOLOGY.pptx
1_INTRODUCTION TO PHARMACOLOGY.pptx1_INTRODUCTION TO PHARMACOLOGY.pptx
1_INTRODUCTION TO PHARMACOLOGY.pptx
 
Drug development process
Drug development processDrug development process
Drug development process
 

Plus de Dr NEETHU ASOKAN

Gram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptx
Gram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptxGram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptx
Gram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptx
Dr NEETHU ASOKAN
 

Plus de Dr NEETHU ASOKAN (20)

Gram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptx
Gram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptxGram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptx
Gram-Positive-Bacteria-Characteristics-Classification-and-Pathogenicity.pptx
 
Fundamental-Immunology.pptx
Fundamental-Immunology.pptxFundamental-Immunology.pptx
Fundamental-Immunology.pptx
 
Algal-Biotechnology-and-its-Scope.pptx
Algal-Biotechnology-and-its-Scope.pptxAlgal-Biotechnology-and-its-Scope.pptx
Algal-Biotechnology-and-its-Scope.pptx
 
Microbial-Taxonomy-and-Tools.pptx
Microbial-Taxonomy-and-Tools.pptxMicrobial-Taxonomy-and-Tools.pptx
Microbial-Taxonomy-and-Tools.pptx
 
VECTORS.pptx
VECTORS.pptxVECTORS.pptx
VECTORS.pptx
 
BASIC DNA REPAIR MECHANISMS.pptx
BASIC DNA REPAIR MECHANISMS.pptxBASIC DNA REPAIR MECHANISMS.pptx
BASIC DNA REPAIR MECHANISMS.pptx
 
Gene regulation
Gene regulationGene regulation
Gene regulation
 
Antigen antibody reactions
Antigen antibody reactionsAntigen antibody reactions
Antigen antibody reactions
 
Screening of industrial microorganisms
Screening of industrial microorganismsScreening of industrial microorganisms
Screening of industrial microorganisms
 
Vitamin
VitaminVitamin
Vitamin
 
Fermentation of wine
Fermentation of wineFermentation of wine
Fermentation of wine
 
Yeasts
YeastsYeasts
Yeasts
 
Enzyme production
Enzyme productionEnzyme production
Enzyme production
 
Biosynthesis of purine and pyrimidine
Biosynthesis of purine and pyrimidineBiosynthesis of purine and pyrimidine
Biosynthesis of purine and pyrimidine
 
Mutation
MutationMutation
Mutation
 
Genetic code
Genetic codeGenetic code
Genetic code
 
Mapping of genome
Mapping of genomeMapping of genome
Mapping of genome
 
Genetic recombination
Genetic recombinationGenetic recombination
Genetic recombination
 
Fermentation of ABE and butanediol
Fermentation of ABE and butanediolFermentation of ABE and butanediol
Fermentation of ABE and butanediol
 
Fermentation of glutamic acid
Fermentation of glutamic acidFermentation of glutamic acid
Fermentation of glutamic acid
 

Dernier

Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Dernier (20)

Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 

Drug design and discovery ppt

  • 1. A short Introduction to Drug design and discovery neethuasokan
  • 2. What is a drug? • Defined composition with a pharmacological effect • Regulated by the Food and Drug Administration (FDA) • What is the process of Drug Discovery and Development? neethuasokan
  • 3. Drug designing 1)challenging 2)Expensive 3)Time consuming So, Multidisciplinary approach: Computational tools, methodologies for structure guided approach + Global gene expression data analysis by softwares. Hence, 1)Efficiency increased 2)Cost effectiveness 3)Time saved 4)Strategies to overcome toxic side effects neethuasokan
  • 4. Drug design Hence, 1)Efficiency increased 2)Cost effectiveness 3)Time saved 4)Strategies to overcome toxic side effects neethuasokan
  • 5. DRUG DESIGN 2 ways: A)Development of ligands with desired properties for targets having known structure and functions. B)Development of ligands with predefined properties for targets whose structural information may be or may not be known. This, unknown target information can be found by global gene expression data. neethuasokan
  • 6. w drugs are taken?  Inhaled  Injection  Orally  Snorted  Transdermal (Patches)  Through body orifices neethuasokan
  • 7. A Little History of Computer Aided Drug Design • 1960’s - Viz - review the target - drug interaction • 1980’s- Automation - high trhoughput target/drug selection • 1980’s- Databases (information technology) - combinatorial libraries • 1980’s- Fast computers - docking • 1990’s- Fast computers - genome assembly - genomic based target selection • 2000’s- Vast information handling - pharmacogenomics neethuasokan
  • 8. Drug Designing Methods: • Databases: PDB: Experimentally determined structures. NCI: National Cancer Institute. Pubchem: Bulk data available for QSAR for lead discovery. 3D MIND: Information about cytotoxic potency for 60 human cancer cell lines. OSIRIS: To draw chemical structures and predict drug like properties like absorption in body etc. Links at the bottom of the paper. Autodock and Dock6 for docking neethuasokan
  • 9. Toxicity • Toxicology is the study of toxic effects of drugs or other substances on the body • Physicians must weigh therapeutic benefit against the risk of toxicity • Some drugs have a narrow therapeutic-toxic index called the “therapeutic window” • very little difference exists in the therapeutic versus toxic blood level • laboratory drug levels are ordered if the physician suspects toxicity • Toxicity of a drug may affect route of administration neethuasokan
  • 10. Discovery and Development • The time from conception to approval of a new drug is typically 10-15 years • The vast majority of molecules fail along the way • The estimated cost to bring to market a successful drug is now $800 million!! (Dimasi, 2000) neethuasokan
  • 11. Drugs and the Discovery Process• Small Molecules • Natural products • fermentation broths • plant extracts • animal fluids (e.g., snake venoms) • Synthetic Medicinal Chemicals • Project medicinal chemistry derived • Combinatorial chemistry derived • Biologicals • Natural products (isolation) • Recombinant products • Chimeric or novel recombinant products neethuasokan
  • 12. BASICCONCEPT OFTHE DRUGMANAGEMENTCYCLE neethu asokan Management Support Procurement Planning Distribution Utilization Storage
  • 13. Advantages  Patients receive optimal pharmaceutical therapy  Enables consistent and predictable treatment from all levels of providers and at all locations  Allows for improved availability of medicines because of consistent and known usage patterns  Helps provide good outcomes because patients are receiving the best treatment regimen available  Lowers cost neethuasokan
  • 14. Disadvantages  Inaccurate guidelines will provide the wrong information. Often guidelines are based on existing practices rather than evidenced-based medicine.  Guideline development and maintenance takes much time and effort.  STGs may give false sense of security and discourage ongoing critical thinking neethuasokan
  • 15. The biological targets of drug action neethuasokan
  • 16. • Medicine – a legal substance used to treat an illness or ailment • Side effects – an effect that accompanies the expected effect of a drug • Drug allergies – an unwanted effect that accompanies the desired effect of a drug • Overdose – a serious sometimes fatal reaction to a large dose of a drug • Dose – an exact amount of a drug neethuasokan
  • 17. Issues in Drug Discovery • Hits and Leads - Is it a “Druggable” target? • Resistance • Pharmacodynamics • Delivery - oral and otherwise • Metabolism • Solubility, toxicity • Patentability neethuasokan
  • 18. Drug Discovery Without a Lead Penicillins 1928 - Fleming • mold spore contaminates culture dish • left dish on bench top while on vacation • weather was unseasonably cold • particular strain of mold was a good penicillin producer Bacteria lysed by green mold; could not reproduce effect - serendipity. Could not get penicillin in a useful clinical form 1940 - Florey (Oxford) Succeeded in producing penicillin in a useful clinical form. neethuasokan
  • 19. Conclusion • Cancer is common in all the ages and it shows metastasis, angiogenesis and cell death, etc. • So, drugs to cure cancer are necessary. • Except toxicity, drugs are quite tolerable so they are combined with other drugs. • Comparative analysis of gene expression levels between drug treated and non-treated condition should be studied. • If getting superior quality drug than the available ones, clinical trial phases can be performed on them. neethuasokan